In this study, we evaluated the diagnostic yield of an integrated approach combining long-read sequencing of the entire DMD gene with RNA-seq in a cohort of 50 dystrophinopathy patients who had remained undiagnosed following standard MLPA and ES. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.